Retraction
The oncolytic virus in cancer diagnosis and treatment
Paper Information
Record ID:
49889
Author(s):
Journal:
Publication Date:
September 09, 2020
Retraction Date:
November 10, 2023
(2.0 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China
- Jiangsu Key Laboratory of Biological Cancer, Cancer Institute, Xuzhou Medical University, Xuzhou, China
- Department of Oncology, Anhui Medical University, Hefei, China
- Department of Infectious Disease, Zhejiang University, Hangzhou, China
- Department of General Surgery, The First People’s Hospital of Xiaoshan District, Hangzhou, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Frontiers
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (98)
98
Total Citations25
Post-Retraction(25.5%)
73
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
2
Within 30 days
18
Within 1 year
0
After 2+ years
591
Days since retraction (latest)
A Meta-analysis on the Effectiveness of Extracellular Vesicles as Nanosystems for Targeted Delivery of Anticancer Drugs
Suleiman Alhaji Muhammad, Jaafaru Sani Mohammed, Sulaiman Rabiu
Molecular Pharmaceutics
Published: Jan 2023
9 citations
9 citations
311 days before retraction
Genome-wide analysis of circulating tumor DNA methylation profiles in cerebrospinal fluid: a clinical trial of oncolytic virus for glioblastoma.
Lin Dai, Zixuan Jing, Yi Zhu et al. (5 authors)
PubMed
Published: Jan 2023
4 citations
4 citations
313 days before retraction
Oncolytic virus cancer therapeutic options and integration of artificial intelligence into virus cancer research
Vaishak Kaviarasan, Barath Ragunath, Ramakrishnan Veerabathiran
Elsevier eBooks
Published: Jan 2023
1 citation
1 citation
313 days before retraction
Rational selection of an ideal oncolytic virus to address current limitations in clinical translation
Rupsa Basu, Chad M. Moles
International review of cell and molecular biology
Published: Jan 2023
2 citations
2 citations
313 days before retraction
Research progress in the treatment of glioblastoma by an oncolytic virus
X Shao, Wei Ni, Xiaobin Xu et al. (4 authors)
Glioma
Open Access
Published: Jan 2023
313 days before retraction
Aptamers Enhance Oncolytic Viruses’ Antitumor Efficacy
М. А. Дымова, Anna S. Kichkailo, Elena V. Kuligina et al. (4 authors)
Pharmaceutics
Open Access
Published: Dec 2022
7 citations
7 citations
314 days before retraction
Influencing factors and prediction methods of radiotherapy and chemotherapy in patients with lung cancer based on logistic regression analysis
Yuxia Liu, Chang Xu, Chengyan Xing et al. (4 authors)
Scientific Reports
Open Access
Published: Dec 2022
2 citations
2 citations
339 days before retraction
Oncolytic Viruses for the Treatment of Bladder Cancer: Advances, Challenges, and Prospects
Henglong Hu, Qi‐Dong Xia, Jia Hu et al. (4 authors)
Journal of Clinical Medicine
Open Access
Published: Nov 2022
5 citations
5 citations
349 days before retraction
Oncolytic virus: A catalyst for the treatment of gastric cancer
Junqing Wang, Linyong Du, Xiangjian Chen
Frontiers in Oncology
Open Access
Published: Nov 2022
4 citations
4 citations
351 days before retraction
Virotherapy
Sathiamoorthi Thangavelu, Saikishore Ramanthan, Palanivel Velmurugan et al. (4 authors)
Elsevier eBooks
Published: Nov 2022
1 citation
1 citation
364 days before retraction
Evaluation of MMR live attenuated vaccine oncolytic potential using Ehrlich ascites carcinoma in a murine model
Sara T. Hassan, Aly F. Mohamed, Nourhan H. AbdelAllah et al. (4 authors)
Medical Oncology
Open Access
Published: Oct 2022
6 citations
6 citations
377 days before retraction
Cancer Stem Cells in Hepatocellular Carcinoma: Intrinsic and Extrinsic Molecular Mechanisms in Stemness Regulation
Xiaona Fang, Qian Yan, Shan Liu et al. (4 authors)
International Journal of Molecular Sciences
Open Access
Published: Oct 2022
28 citations
28 citations
392 days before retraction
Cancer as a Dysfunctional Immune Disorder: Pro-Tumor TH1-like Immune Response and Anti-Tumor THαβ Immune Response Based on the Complete Updated Framework of Host Immunological Pathways
Yi-Hsin Lee, Kuo‐Wang Tsai, Kuo‐Cheng Lu et al. (5 authors)
Biomedicines
Open Access
Published: Oct 2022
16 citations
16 citations
400 days before retraction
Isolation and Characterization of a Discrete Genetically Homogeneous Viral Subpopulation of Mumps Virus RS-12 Strain with Superior Oncolytic Potency Compared to Its Progenitor Virus
Behnam Alirezaie, Abolhasan Foroughi, Ashraf Mohammadi
International Journal of Cancer Management
Open Access
Published: Sep 2022
417 days before retraction
Targeted Regulation and Cellular Imaging of Tumor-Associated Macrophages in Triple-Negative Breast Cancer: From New Mechanistic Insights to Candidate Translational Applications
Anupama Hooda-Nehra, Tracey L. Smith, Alejandra I. Ferrer et al. (7 authors)
IntechOpen eBooks
Open Access
Published: Aug 2022
440 days before retraction
Stem cell-based therapy for human diseases
Duc M. Hoang, Phuong T. Pham, Trung Q. Bach et al. (12 authors)
Signal Transduction and Targeted Therapy
Open Access
Published: Aug 2022
696 citations
696 citations
461 days before retraction
Therapeutic Efficacy of Oncolytic Viruses in Fighting Cancer: Recent Advances and Perspective
Ghazal Asadi Garmaroudi, Farzaneh Karimi, Leila Ghanbari Naeini et al. (5 authors)
Oxidative Medicine and Cellular Longevity
Open Access
Published: Jul 2022
14 citations
14 citations
476 days before retraction
SARS-CoV-2 and cancer: the intriguing and informative cross-talk
Hadi Goubran, Julie Stakiw, Jerard Seghatchian et al. (5 authors)
Transfusion and Apheresis Science
Open Access
Published: Jun 2022
7 citations
7 citations
514 days before retraction
Phage‐Derived Oncolytic Viruses with 3C from Seneca Valley Virus for Targeted Therapy of Cervical Cancer
Tingting Liu, Ningwei Zhao, Mingze Shi et al. (6 authors)
Advanced Therapeutics
Published: Jun 2022
1 citation
1 citation
518 days before retraction
Tracing New Landscapes in the Arena of Nanoparticle-Based Cancer Immunotherapy
Aisha Shigna Nadukkandy, Eshani Ganjoo, Ankit Singh et al. (4 authors)
Frontiers in Nanotechnology
Open Access
Published: Jun 2022
8 citations
8 citations
520 days before retraction
Oncolytic virus delivery modulated immune responses toward cancer therapy: Challenges and perspectives
Mohsen Keshavarz, Seyed Mohammad Miri, Emad Behboudi et al. (6 authors)
International Immunopharmacology
Open Access
Published: May 2022
33 citations
33 citations
535 days before retraction
A Window of Opportunity to Overcome Therapeutic Failure in Neuro-Oncology
Michael A. Vogelbaum, Gongbo Li, Amy B. Heimberger et al. (7 authors)
American Society of Clinical Oncology Educational Book
Open Access
Published: May 2022
11 citations
11 citations
542 days before retraction
Tumor‐targeted fluorescence labeling systems for cancer diagnosis and treatment
Hiroshi Tazawa, Kunitoshi Shigeyasu, Kazuhiro Noma et al. (9 authors)
Cancer Science
Open Access
Published: Apr 2022
11 citations
11 citations
579 days before retraction
Oncolytic adenovirus-mediated intratumoral expression of TRAIL and CD40L enhances immunotherapy by modulating the tumor microenvironment in immunocompetent mouse models
Wenmo Liu, Xupu Wang, Xinyao Feng et al. (12 authors)
Cancer Letters
Published: Mar 2022
17 citations
17 citations
599 days before retraction
Genetic Therapy and Molecular Targeted Therapy in Oncology: Safety, Pharmacovigilance, and Perspectives for Research and Clinical Practice
Sabrina Orzetti, Federica Tommasi, Antonella Bertola et al. (9 authors)
International Journal of Molecular Sciences
Open Access
Published: Mar 2022
16 citations
16 citations
610 days before retraction
Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus
Volker Schirrmacher
Biomedicines
Open Access
Published: Feb 2022
31 citations
31 citations
620 days before retraction
Correlation of SARS‑CoV‑2 to cancer: Carcinogenic or anticancer? (Review)
Yingshuang Li, Hua-Cheng Ren, Jianhua Cao
International Journal of Oncology
Open Access
Published: Feb 2022
24 citations
24 citations
620 days before retraction
Immunotherapy for Pediatric Cancer
Wafaa M. Rashed
Springer eBooks
Published: Jan 2022
1 citation
1 citation
678 days before retraction
Advances in the clinical development of oncolytic viruses.
Ke Li, Yalong Zhao, Xiaocong Hu et al. (6 authors)
PubMed
Published: Jan 2022
28 citations
28 citations
678 days before retraction
Oncolytic virotherapy and the current approaches in veterinary medicine
Bengü Bilgiç, Banu Dokuzeylül, Mehmet Erman Or
German Journal of Veterinary Research
Open Access
Published: Jan 2022
678 days before retraction
Immunotherapeutic Strategies for Glioma Treatment
Athina Malliou, Athanasios P. Kyritsis, George Α. Alexiou
Interdisciplinary cancer research
Published: Jan 2022
1 citation
1 citation
678 days before retraction
Oncolytic adenovirus Delta-24- RGD engineered to express 4-1BBL or OX40L as therapeutic approach for diffuse intrinsic pontine gliomas
Virginia Laspidea
Unknown Journal
Open Access
Published: Jan 2022
678 days before retraction
Immunotherapies for hepatocellular carcinoma
Justin K. H. Liu, Andrew F. Irvine, Rebecca Jones et al. (4 authors)
Cancer Medicine
Open Access
Published: Dec 2021
64 citations
64 citations
686 days before retraction
Co-immunizing with HMGB1 enhances anti-tumor immunity of B7H3 vaccine in renal carcinoma
Huanyou Sun, Juan Li, Wenwen Hu et al. (14 authors)
Molecular Immunology
Published: Sep 2021
8 citations
8 citations
778 days before retraction
High-dose VitC plus oncolytic adenoviruses enhance immunogenic tumor cell death and reprogram tumor immune microenvironment
Jinhu Ma, Chunxue Zhang, Gang Shi et al. (15 authors)
Molecular Therapy
Open Access
Published: Sep 2021
17 citations
17 citations
781 days before retraction
Oncolytic virus therapy in cancer: A current review
Jonathan Santos Apolonio, Vinícius Lima de Souza Gonçalves, Maria Luísa Cordeiro Santos et al. (9 authors)
World Journal of Virology
Open Access
Published: Sep 2021
115 citations
115 citations
785 days before retraction
A review on the advances and challenges of immunotherapy for head and neck cancer
Gang Cheng, Hui Dong, Chen Yang et al. (8 authors)
Cancer Cell International
Open Access
Published: Jul 2021
47 citations
47 citations
832 days before retraction
Oncolytic Adenovirus: Prospects for Cancer Immunotherapy
Yaqi Zhao, Zheming Liu, Lan Li et al. (8 authors)
Frontiers in Microbiology
Open Access
Published: Jul 2021
73 citations
73 citations
842 days before retraction
Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy
Ramazan Rezaei, Hadi Esmaeili Gouvarchin Ghaleh, Mahdieh Farzanehpour et al. (8 authors)
Cancer Gene Therapy
Open Access
Published: Jun 2021
78 citations
78 citations
871 days before retraction
Antitumor immunity enhancement through Newcastle viral oncolysate in mice model: A promising method to treat tumors
Amir Sasan Mozaffari Nejad, Fatemeh Fotouhi, Parvaneh Mehrbod et al. (4 authors)
Saudi Journal of Biological Sciences
Open Access
Published: Jun 2021
7 citations
7 citations
875 days before retraction
Relapsed and refractory classical Hodgkin lymphoma: could virotherapy help solve the equation?
Selma Addou, Clémentine Sarkozy, Julien Lazarovici et al. (9 authors)
Human Vaccines & Immunotherapeutics
Open Access
Published: Jun 2021
1 citation
1 citation
885 days before retraction
Reovirus and Rotaviruses
Hoorieh Soleimanjahi, Fatemeh Hosseini Heydarabadi
Elsevier eBooks
Published: Apr 2021
1 citation
1 citation
924 days before retraction
Oncolytic reovirus induces ovarian cancer cell apoptosis in a TLR3-dependent manner
Yuanyuan An, Xianyao Wang, Xuxian Wu et al. (10 authors)
Virus Research
Published: Apr 2021
12 citations
12 citations
924 days before retraction
Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies
Johannes P.W. Heidbuechel, Christine E. Engeland
Journal of Hematology & Oncology
Open Access
Published: Apr 2021
81 citations
81 citations
938 days before retraction
Neoantigen: A New Breakthrough in Tumor Immunotherapy
Zheying Zhang, Manman Lu, Yu Qin et al. (7 authors)
Frontiers in Immunology
Open Access
Published: Apr 2021
229 citations
229 citations
938 days before retraction
Use of Salmonella Bacteria in Cancer Therapy: Direct, Drug Delivery and Combination Approaches
Fereshteh Badie, Maryam Ghandali, Seyed Alireza Tabatabaei et al. (12 authors)
Frontiers in Oncology
Open Access
Published: Mar 2021
48 citations
48 citations
983 days before retraction
The role of NK cells in oncolytic viral therapy: a focus on hepatocellular carcinoma
Frazer Warricker, Salim I. Khakoo, Matthew D. Blunt
Journal of Translational Genetics and Genomics
Open Access
Published: Jan 2021
6 citations
6 citations
1043 days before retraction
New viral vectors for infectious diseases and cancer
Emanuele Sasso, Anna Morena D’Alise, Nicola Zambrano et al. (6 authors)
Seminars in Immunology
Open Access
Published: Aug 2020
96 citations
96 citations
1196 days before retraction
Quick Stats
Total Citations:
98
Years Since Retraction:
2.0 years
Open Access:
Yes
Last Checked:
Jul 24, 2025